Literature DB >> 18290354

Gadolinium and nephrogenic systemic fibrosis: the evidence of things not seen.

Jonathan Kay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18290354     DOI： 10.3949/ccjm.75.2.112

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  4 in total

Review 1.  Gadolinium-based contrast agents: why nephrologists need to be concerned.

Authors:  Katarina Leyba; Brent Wagner
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-03       Impact factor: 2.894

Review 2.  Contemporary management of phosphorus retention in chronic kidney disease: a review.

Authors:  Fateme Shamekhi Amiri
Journal:  Clin Exp Nephrol       Date:  2015-06-02       Impact factor: 2.801

Review 3.  Pathophysiology of gadolinium-associated systemic fibrosis.

Authors:  Brent Wagner; Viktor Drel; Yves Gorin
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-04

Review 4.  Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.